Fusion toxins are hybrid proteins consisting of peptide ligands linked through amide bonds to poly peptide toxins. The ligand directs the molecule to the surface of target cells and the toxin enters the cytosol and induces cell death. Ricin is an excellent candidate for use in fusion toxins because of its extreme potency, the extensive knowledge of its atomic structure and the lack of prior immunological exposure in patients. We synthesized a baculovirus transfer vector with the polyhedrin promoter followed sequentially from the 5' end with DNA encoding the gp67A leader sequence, the tripeptide ADP, IL-2 (interleukin-2), another ADP tripeptide and RTB (ricin toxin B chain) with lectinsite mutations W37S and Y248H.
Introduction
Ricin toxin, the heterodimeric 65 kDa glycoprotein produced in the seeds of Ricinus communis plants, is composed of a 33 kDa lectin B chain [ricin toxin B chain (RTB)] disulfide linked to a 32 kDa RNA /V-glycosidase A chain [ricin toxin A chain (RTA)] (Olsnes et al, 1974) . The toxin acts sequentially to bind ji-galactosyl pyranoside moieties on cell surface glycoproteins (Baenziger and Fiete, 1979) , internalizes by receptor-mediated endocyotosis into endosomes (Sandvig and Olsnes, 1982) and undergoes sorting in the Golgi (Youle and Colombatti, 1987) followed by transport to a distal intracellular compartment which may be the endoplasmic reticulum (Wales et al, 1993) . Interchain disulfide reduction (Masuho et al, 1982) and unfolding of RTA (Argent et al, 1994) lead to translocation across the membrane bilayer and release of RTA into the cytosol. Once in the cytosol, RTA catalytically depurinates a critical adenine base from 28S ribosomal RNA causing loss of elongation factor binding to the ribosome and irreversible inactivation of protein synthesis (Endo and Tsurugi, 1987) .
Targeted toxins employing ricin have been synthesized and used in clinical trials of lymphoma with moderate clinical activity (Grossbard et al, 1993; Sausville et al, 1995) . The normal tissue binding sites on RTB have been removed by either deletion of the entire RTB subunit (Vitetta et al, 1982) or chemically blocking the lectin sites on RTB with an affinity cross-linker (Lambert et al, 1991 ). The toxic moieties were then chemically conjugated to antilymphoma murine monoclonal antibodies. The limited clinical efficacy observed may in part have been due to the large size of the conjugates (200 kDa) reducing capillary permeability, the heterogeneity of the hybrid proteins (the A'-succinimidyl coupling agent reacts with any lysine on the antibody ligand) and the loss of the intoxication enhancement functions of RTB.
One approach to improving the pharmacologic properties of targeted ricin molecules is to genetically engineer the toxin and ligand into a single small well denned molecule. O'Hare expressed an RTA-diphtheria toxin loop-Staphylococcal protein A chimera in Escherichia coli (O'Hare et al, 1990) . The protein was enzymatically cleaved with trypsin, mixed with antibody and tested for cytotoxicity to antigenpositive cells. The immunoconjugate was cytotoxic, but the disulfide loop was exposed on die surface of the conjugate and readily reduced. The molecule was large (>200 kDa) and heterogeneous due to varying sites of protein Aimmunoglobulin binding. Cook reported the expression of IL-2-diphtheria toxin loop-RTA and IL-2-factor Xa recognition sequence-RTA fusions (Cook et al, 1993) . In both cases, the disulfide loop failed to form and proteolysis with trypsin or factor Xa released free ligand and toxin. Uncleaved chimeras showed no toxicity to IL-2 receptor bearing cells. Westby expressed preproricin containing a factor Xa-specific site in the linker sequence in Xenopus oocytes (Westby et al, 1992) . The product was produced at very low levels and had minimal protease sensitivity and no IL-2 binding specificity.
We have chosen an alternative approach for genetic engineering of ricin. We attached the ligand, IL-2, to the N-terminus of RTB and expressed the protein with a GP67A leader peptide in insect cells (Frankel et al, 1995) . Recombinant protein was purified from insect cell supernatants by affinity chromatography and reassociated widi RTA. The fusion toxin was obtained in milligram yields and showed selective toxicity to IL-2 receptor bearing cells in the presence of lactose. We have subsequently produced recombinant RTB molecules with deficient lectin-site function (Frankel et al, 1996a,b) . Based on this work, we have chosen to link IL-2 to the RTB double lectin-site mutant W37S/Y248H and reassociate the product with RTA. In this paper, we report the expression, purification and characterization of a plant fusion toxin suitable for preclinical and clinical development. (Frankel et al, 1996) was restricted with BamHl, bound and eluted from a silica matrix, digested with calf intestinal phosphatase, heat inactivated and repurified on a silica matrix. The fla/nHI fragment encoding IL-2 prepared by PCR of pDW27 plasmid DNA as described previously (Frankel et al., 1995) was isolated from pUC119-IL-2 by digestion of cesium chloride density gradient purified plasmid with BamHl, agarose electrophoresis and binding and elution from a silica matrix. The 406 bp fragment was subcloned into pAcGP67A-ADP-RTB[W37S/Y248H]. The expression vector was maintained in INVaF' E.coli using 100 Hg/ml ampicillin. Plasmid isolated by alkaline lysis followed by cesium chloride density gradient centrifugation was doublestranded dideoxy sequenced by the Sanger method (Sanger etal, 1977) .
Materials and methods

Materials
Expression of fusion toxin
Sf9 Spodoptera frugiperda ovarian cells (2X10 6 ) maintained in TMNFH medium supplemented with 10% fetal calf serum and 50 |ig/ml gentamicin sulfate were co-transfected 914 with P AcGP67A-ADP-IL-2-ADP-RTB[W37S/Y248H] DNA (4 ng) and 0.5 ug of BaculoGold AcNPV DNA following the recommendations of the supplier. At 6 days post-transfection, the medium was centrifuged and the supernatant tested in a limiting dilution assay with Sf9 cells and dot blots with random primer [ 32 P]dCTP-labeled RTB DNA as described previously (Frankel et al., 1994) . Positive wells were identified and supernatants reassayed by limiting dilution until all wells up to 10" 8 dilution were positive. Two rounds of selection were required. Recombinant virus in the supernatant was then amplified by infecting Sf9 cells at a multiplicity of infection (m.o.i.) of 0.1, followed by collection of day 7 supernatants. Recombinant baculovirus was then used to infect 2X10 8 Sf9 cells at an m.o.i. of 5-10 in 150 ml of EX-CELL400 medium with 25 mM a-lactose in spinner flasks. Media supernatants containing ADP-IL-2-ADP-RTB[W37S/Y248H] were collected at day 6 post-infection. Protein purification Media supernatants were adjusted to 0.01% sodium azide and maintained through all purification steps at 4°C. The supernatants were concentrated 15-fold by vacuum dialysis, centrifuged at 3000 g for 10 min to remove precipitate, dialyzed against 50 mM NaCl, 25 mM Tris (pH 8), 1 mM EDTA, 0.01% sodium azide and 25 mM a-lactose (NTEAL), ultracentrifuged at 100 000 g for 1 h and bound and eluted from a P2 monoclonal antibody-acrylamide matrix as described previously (Frankel et al., 1994) . P2 is an anti-RTB monoclonal antibody. The affinity matrix was prepared using Ultralink azlactone functionality bisacrylamide following the recommendations of the manufacturer. Recombinant protein was absorbed on the column in NTEAL, washed with 50 mM NaCl, 25 mM Tris (pH 8), 1 mM EDTA, 0.1% Tween 20, 0.01% sodium azide, 25 mM a-lactose and eluted with 0.1 M triethylamine hydrochloride (pH 11). The eluate was neutralized with 1/10 volume of 1 M sodium phosphate (pH 4.25) and stored at-20°C until assayed. Four preparations were made.
Characterization of recombinant protein
The total protein concentration of the affinity column eluate was determined by measuring the absorbance at 280 nra. Since the optical densities of a 1 mg/ml solution of RTB and IL-2 were 1.4 and 0.7, respectively, a 1 mg/ml solution of fusion protein should have a mass-average optical density of 1.16. Protein was also quantitated by Bio-Rad protein assay according to the recommendations of the supplier. Aliquots of ADP-IL-2-ADP-RTB[W37S/Y248H], plant RTB and prestained low molecular weight standards were subjected to a reducing 15% SDS-PAGE, stained with Coomassie Blue R-250 and scanned on an IB AS automatic image analysis system (Kontron, Germany).
Immunological analysis was performed using both an ELISA and immunoblot format. Costar EIA microtiter wells were coated with 100 nl of 5 \ig/m\ of monoclonal antibody P2, P8 or P10 reactive with RTB or monoclonal antibody to IL-2, washed with PBS plus 0.1 % Tween 20, blocked with 3% BSA, rewashed and incubated with samples of ADP-IL-2-ADP-RTB[W37S/Y248H], human IL-2 or plant RTB, rewashed, reacted with 1:400 rabbit antibody to ricin or 1:500 rabbit antibody to IL-2, washed again, incubated with 1:5000 alkaline phosphatase conjugated goat anti-(rabbit IgG), rewashed, developed with 1 mg/ml p-nitrophenylphosphate in diethanolamine buffer (pH 9.6) and read on a Bio-Rad 450 microplate reader at 405 nm.
Aliquots of ADP-IL-2-ADP-RTB[W37S/Y248H], bacterial IL-2, recombinant RTB, plant RTB and prestained low molecular weight protein standards were subjected to a reducing 15% SDS-PAGE, transferred to nitrocellulose, blocked with 10% Carnation non-fat dry milk-0.1% Bovine serum albumin (BSA)-0.1% Tween 20, washed with PBS plus 0.05% Tween 20, reacted with either 1:400 rabbit antibody to ricin or 1:100 mouse monoclonal antibody to IL-2 (5 |ig/ml), rewashed, incubated with alkaline phosphatase conjugated goat anti-(rabbit IgG) or anti-(mouse IgG), washed again and developed with the Vectastain alkaline phosphatase kit. Reassociation with RTA An 18 |ig amount of ADP-IL-2-ADP-RTB[W37S/Y248H] was mixed with 54 u:g of plant RTA in a total volume of 0.5 ml of 0.1 M triethylamine-0. l M sodium phosphate (pH 7), shaking overnight at room temperature. The reaction mixture was then analyzed by a modified ricin ELISA described previously (Frankel et al., 1996) . Reassociated mixtures were also analyzed by non-reducing SDS-PAGE followed by immunoblots with P2 and P10 anti-RTB monoclonal antibodies (10 (ig/ml each), monoclonal antibody to IL-2 (5 (ig/ml) or monclonal antibody aBR12 to RTA (10 (ig/ml). Densitometric scanning with the automatic image analysis system was done to quantify the shift of immunoreactive material from 50 to 80 kDa. Lectin activity of heterodimer Asialofetuin (1 ng/ml) was bound to Costar El A plate wells and an ELISA was performed as detailed previously with samples of ADP-lL-2-ADP-RTB[W37S/Y248H]-RTA and castor bean ricin (Frankel et al., 1996) . Briefly, the asialofetuin coated wells were washed with PBS plus 0.1% Tween 20, blocked with 3% BSA, rewashed and incubated with 12 different concentrations of samples in EX-CELL400, rewashed and reacted with 100 u.1 of biotinylated aBR12 monoclonal anti-RTA antibody, rewashed and incubated with streptavidinalkaline phosphatase, washed again and developed with p-nitrophenyl phosphate in 50 mM diethanolamine (pH 9.6). The absorbance of the wells was measured at 405 nm on a microtiter plate reader. The concentration of protein giving half-maximum binding was calculated.
IL-2 receptor binding specificity
HUT 102 human T leukemia cells bearing the high-affinity IL-2 receptor, CEM human leukemia cells bearing the intermediate affinity IL-2 receptor and KB human epidermoid carcinoma cells lacking the IL-2 receptor were washed with PBS and attached to polylysine-coated tissue culture dishes and centrifuged at 2000 g for 10 min. The cells were then incubated live at 4°C. The cells were washed with 2 mg/ml BSA in PBS and incubated in PBS plus BSA with 1 ug/ml castor bean ricin or IL-2-lectin-deficient ricin. The incubation was done at 4°C. The cells were then washed with PBS and incubated with aBR12 mouse monoclonal antibody to RTA (5 |ig/ml) plus BSA for 30 min at 4°C. The cells were then washed with PBS and reacted with goat anti-(mouse Ig) conjugated to rhodamine (Jackson ImmunoResearch, West Grove, PA) at 25 (ig/ml for 30 min at 4°C. The cells were washed again in PBS and fixed in 3.7% formaldehyde in PBS, mounted under a No. 1 coverslip in glycerol-PBS (90:10) and examined using a Zeiss Axioplan epifluorescence microscope. Cytotoxicity to mammalian cells Measurement of protein synthesis inhibition by ricin and ADP-IL-2-ADP-RTB[W37S/Y248H]-RTA in cultured cells was done as described previously using HUT 102, CEM and KB cells (Frankel et al, 1995) . All assays were performed in triplicate. Twelve different concentrations of toxins were used. The ID X was the concentration of protein which inhibited protein synthesis by 50% compared with control wells without toxin. There was no purification step after heterodimer reassociation. The free RTA concentration at the highest concentration of heterodimer in the assay (5X10~7 M) was 10~7 M. On all three cell lines, the ID^ for free RTA was 2-3X10" 6 M (Tagge et al., 1995) . Thus, in the range of heterodimer ID^ (1CT 10 -10~1 2 M), the free RTA concentration (2X10-"-2X10-13 M) should not produce cytotoxicity.
Blocking of cytotoxicity with IL-2 or lactose HUT102 cells (1.5X10 4 ) were placed in sterile Eppendorf tubes at 4°C in 100 (il leucine-poorRPMI1640 + 10%dialyzed fetal calf serum with or without 20 (ig/ml IL-2 or 60 mM a-lactose. Dilutions of IL-2-lectin-site modified ricin and ricin at varying concentrations were added in identical medium with or without IL-2 or lactose and incubated at 4°C for 30 min. Cells were pelleted at 2000 g for 5 min, washed once with leucine-poor RPMI1640 + 10% dialyzed fetal calf serum, resuspended in 150 |il of the same medium and incubated at 37°C in 5% CO 2 for 24 h. 
Results
Yield and purity of ADP-IL-2-ADP-RTB[W37S/Y248H]
Five individual preparations from 100 ml of cell supernatants were partially purified. Peak eluate fractions contained 172, 107, 86, 175 and 100 ug of protein based on the absorbance at 280 nm. The Bio-Rad protein assay gave values of 80, 64, 80 and 84 (ig of protein, respectively for preparations I, 3, 4 and 5, using BSA standard. Densitometry of Coomassiestained gels showed only a single detectable band at 50 kDa in each preparation (Figure 1 ). However, P2 antibody ELISA showed the concentration of anti-RTB immunoreactive protein was 38, 50, 18, 28 and 30 (ig, respectively. Thus, the purity was between 16 and 47% based on absorbance, Bio-Rad protein assay and densitometry of Coomassie-stained gels.
Immunologic cross-reactivity of ADP-IL-2-ADP-RTB[W37S/ Y248H]
Different monoclonal antibodies to RTB (P2, P8 and P10) and an antibody to IL-2 reacted similarly with the fusion molecule based on antibody capture ELISA. The concentration of the fusion molecule was based on a comparison of P2 antibody binding with plant RTB, so that its relative binding is taken as 100%. Antibody P8 bound 140% as well with the fusion molecule as with plant RTB. Antibody P10 bound 150% as well with IL-2-lectin-deficient RTB as with plant RTB. Antibody to IL-2 bound the hybrid molecule 65% as well as with recombinant human IL-2 on a molar basis.
Immunoblots demonstrated reactivity with the same 52 kDa band using anti-RTB or anti-IL-2 antibodies (Figure 2A and B). No weaker bands at lower molecular weight were observed with either set of antibodies, suggesting the partial proteolysis found with IL-2-'wild-type' RTB was not present with the lectin-deficient chimera. Reassociation with RTA Two preparations of fusion toxin heterodimer were made. Under the reaction conditions [10" 6 M of IL-2-lectin-deficient RTB and 3X1O" 6 M of plant RTA, 0.1 M triethylamine-0.1 M sodium phosphate (pH 7), room temperature, room air], 50% reassociation was observed in one reaction and 60% reassociation in the other. The results from the sandwich ricin ELISA were confirmed by immunoblots with antibodies to RTB, RTA and IL-2 ( Figure 3A-C) .
Lectin activity and IL-2 receptor binding of the heterodimer ADP-IL-2-ADP-RTB[W37S/Y248H
]-RTA bound 1% as well as plant ricin to immobilized asialofetuin. Specificity for the high-affinity IL-2 receptor was demonstrated on a live cell immunofluorescence assay (Figure 4) . The IL-2 fusion toxin bound to HUT 102 cells, but bound minimally or not at all to CEM cells and KB cells.
Cell cytotoxicity
Cytotoxicities of fusion heterodimer and plant ricin for different cell lines are shown in Table I . Ricin was uniformly toxic to all three cell lines tested with/D 5O s of 5X10"
12
, 3X]0-|2 and IX10-" M for HUT102, CEM and KB cells, respectively. Similarly, IL-2-wild-type RTB-RTA was also toxic to all three cell lines in the absence of lactose with /D 5 nS of 4X 10~1 2 M on HUT 102, CEM and KB cells as described previously (Frankel et aL, 1995) . In contrast, the fusion toxin displayed The experiments with IL-2-wild-type ricin were performed as described previously (Frankel et al., 1995). significant cytotoxicity only towards the high-affinity IL-2 receptor bearing HUT 102 cells (/D 50 = 5X10" 12 M) ( Figure  5A ). The /D50S of fusion toxin on the other cell lines were two orders of magnitude higher (ID^ = 2X10" 10 and 1X10" 9 M on CEM and KB cells, respectively) ( Figure 5B and C) . Thus, the in vitro therapeutic window was 200-fold. The IDt o the ADP-IL-2-ADP-RTB[W37S/Y248H] protein alone was >10" 8 M. IL-2 receptor-mediated cell toxicity was tested by blocking experiments with excess IL-2 or a-lactose (Figure 6 ). Excess IL-2 reduced IL-2-lectin-deficient-RTB-RTA toxicity towards HUT102 cells by 44-fold (the ID^ was 4X10"" M with IL-2 and 9X10"' 3 M without IL-2). In contrast, excess IL-2 had no effect on ricin toxicity (ID^ = 4X10~1 3 M with and without IL-2). Lactose competition reduced ricin toxicity 100-fold (the /£>5 0 with lactose was 4XIO~1 0 M and without lactose 4X10" 12 M). Again, IL-2-lectin-deficient ricin behaved uniquely. The ID 50 with lactose was 1.5X 10~1 2 M and without lactose 4.5 X 10~1 2 M. Thus, lactose had negligible or enhancing effects on cytotoxicity of the fusion toxin.
Discussion
The first step in the synthesis of targeted toxins is removal or modification of the normal tissue binding sites on the toxin. Ricin binds to cells via lectin sites on RTB (Olsnes et al, 1974) . Studies with synthetic methyl a-Iactoside analogs showed that hydroxyl groups at positions 3, 4 and 6 of the a-D-galactopyranose moiety were required for ricin binding (Rivera-Sagredo et al, 1991) . Equilibrium dialysis measurements with ricin showed low-affinity (K a = 10"" 4 M"') binding of galactose and lactose (Zentz et al, 1978) and high affinity (K a = 10~7-10" 8 M~') binding to complex oligosaccharides and cell surfaces (Sandvig et al, 1976; Baenziger and Fiete, 1979) . These results suggested that multiple low-affinity sugar binding sites on ricin interacted with complex oligosaccharides and cells to yield high-affinity binding. The X-ray diffraction analysis of ricin crystals provided a structural basis for multiple binding functions. RTB has two domains each with three subdomains (Rutenber and Robertus, 1991) . The six subdomains have similar folding and primary amino acid sequence and resemble the primitive galactose binding fold in discoidin I from the slime mold Dictyostelium discoideum. In each Bidentate hydrogen bonds were observed between D22 and D234 and the C3,C4 hydroxyls of the galactosyl moiety. Q35, N46 and N255 contributed additional hydrogen bonds to C6 and C3 hydroxyls, respectively. The aromatic rings of W37 and Y248 provide hydrophobic interactions with the non-polar C4-C6 atoms of the galactose ring. Biochemical modification studies confirmed participation of amino acid residues in subdomains la and 2y in sugar binding. /V-Bromosuccinimide modification of W37 reduced sugar binding (Hatakeyama etai, 1986) and jV-acetylimidazole O-acetylation of Y248 altered lactose affinity (Youle et aL, 1981) .
This structural information was used to design recombinant ricin molecules with lectin sites modified by site-specific mutagenesis. While some of these mutants displayed decreased lectin site function, yields of recombinant product were very low. Cos cell RTB N255A was barely detectable in cell supernatants (Vitetta and Yen, 1990) . Xenopus laevis oocyte expressed subdomain la and 2y RTB mutants were recovered at nanogram levels (Wales et aL, 1991) , and RTB mutants produced as bacteriophage gene III protein fusions were measured bound on phage particles (Lehar et aL, 1994) . We recently reported a baculovirus-insect cell expression system 918 which permits production of milligram quantities of wildtype and mutant RTBs (Frankel et aL, 1994 (Frankel et aL, , 1995 (Frankel et aL, , 1996 . Modification of single lectin sites produced less than a 10-fold reduction in sugar-binding affinity, and modifications of two lectin sites yielded 25-100-fold decreases in sugar binding. There were variable yields. The double-site mutant with changes in charged residues, D22E/D234E, was produced at low levels (0.02 mg/1). In contrast, the mutant with alterations in the aromatic residues, W37S/Y248H, was recovered in amounts 10% of wild-type at 0.27 mg/1. The better recovery of the latter mutant may be due to improved folding and solubility. This mutant was selected for generation of fusion toxins.
The next step in generating fusion toxins is coupling a cellselective ligand. We initially chose to study IL-2 receptor targeting, because of the specificity of this target antigen to normal and malignant hematopoietic cells and the prior experience of other laboratories in producing targeted toxins to this antigen (Williams et aL, 1990; Engert et aL, 1991; Kreitman and Pastan, 1994) . Attachment of IL-2 to the N-terminus of wild-type RTB did not previously alter immunologic reactivity, lectin activity, IL-2 receptor binding activity or yield (Frankel et aL, 1995) . IL-2-wiId-type RTB was produced at 1 mg/1 versus 3 mg/1 for RTB alone. The yields of ADP-IL-2-ADP-RTB[W37S/Y248H] were 0.34 mg/1 insect cell culture, similar to the yields of the parent double-site mutant. The IL-2-lectin-deficient RTB fusion molecule showed immunoreactivity with antibodies to IL-2 and RTB by both ELISA and Western blots. These results are evidence of proper folding of both the EL-2 and RTB domains.
The third requirement for fusion toxins is the presence of an active toxophore domain. We chose to use RTA as the toxic polypeptide. RTB has an extensive surface region and free thiol group for coupling to RTA (Rutenber and Robertus, 1991) . The K a of RTB-RTA association is KT 6 M" 1 , hence even at low subunit concentrations heterodimer formation is favored (Lewis and Youle, 1986) . Our experiments employed concentrations of about lO" 6 M, so we expected ~50% of EL-2-lectin-deficient RTB to reassociate with RTA. Our observation of 50-60% heterodimer formation suggests an excellent efficiency of reassociation. The RTB amino acid residues which interact with RTA include Al, D2, C4, F140, V141, F218, N220, P260 and F262, which are remote from the Nterminus or lectin sites. The recombinant fusion toxin was stable at high dilutions, suggesting disulfide bond formation between RTA C259 and the free thiol of RTB C4 of IL-2-lectin-deficient RTB.
The final IL-2-lectin-deficient ricin fusion toxin was characterized by ELISAs, immunoblots, cell binding assay and cell cytotoxicity assay. The sandwich ELISA demonstrated the presence of both RTA and RTB epitopes on the heterodimer. The immunoblots from non-reducing gels demonstrated the predicted molecular weight of 80 kDa composed of a 33 kDa RTB, a 16 kDa IL-2 and a 31 kDa RTA. Further, the Western blots confirmed the presence of RTA, RTB and IL-2 epitopes on the same molecule. The poor binding to immobilized asialofetuin (1 % relative to plant RTB) and lack of binding to IL-2 receptor negative KB cells was consistent with the double lectin site mutation. Finally, the potent cytotoxicity of the IL-2 fusion toxin to IL-2 receptor positive HUT 102 cells demonstrated that all of the intoxication functions of ricin and binding functions of IL-2 were present. The level of cytotoxicity was similar to DAB 389 IL-2, a diphtheria toxin-IL-2 fusion,
